Hsp90 inhibitors as selective anticancer drugs.


Extract: Cancer drug discovery has traditionally focused on targeting DNA synthesis and cell division, resulting in drugs that show efficacy but have severe side effects, due to their lack of selectivity for tumor cells over normal cells. One truly tumor-specific protein, the mutant kinase BCR-ABL, single-handedly causes chronic myelogenous leukemia and is… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.


Citations per Year

Citation Velocity: 17

Averaging 17 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Slides referencing similar topics